Showing results (281-290 of 528) with videos related to
Sort By:
Pageof 53
The Journal of Infectious Diseases|August 6, 2004
Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160Deborah Lee, Barney S Graham, Ya-Lin Chiu, et al.The Journal of Infectious Diseases|May 13, 2025
Safety, immunogenicity, and protective efficacy in rhesus macaques of a novel recombinant hemagglutinin protein measles virus vaccineJessica H Rubens, Jacqueline K Brockhurst, Shristi Ghimire, et al.Plos One|August 14, 2010
Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicityBarney S Graham, M Juliana McElrath, Michael C Keefer, et al.Viruses|March 6, 2019
Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and AlpacasDanielle R Adney, Lingshu Wang, Neeltje van Doremalen, et al.The Journal of Infectious Diseases|September 24, 2011
Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjectsLindsey R Baden, William A Blattner, Cecilia Morgan, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 28, 2007
Safety and immunogenicity of a Gag-Pol candidate HIV-1 DNA vaccine administered by a needle-free device in HIV-1-seronegative subjectsJorge A Tavel, Julie E Martin, Grace G Kelly, et al.Vaccine|July 13, 2024
Antibody levels against respiratory syncytial virus fusion protein conformations and lack of association with life-threatening infection in previously healthy infantsFlorencia A Bonnin, Laura B Talarico, Fausto M Ferolla, et al.Nature Communications|March 20, 2021
A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodiesAdrian Creanga, Rebecca A Gillespie, Brian E Fisher, et al.Biorxiv : the Preprint Server for Biology|January 27, 2021
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variantsKai Wu, Anne P Werner, Juan I Moliva, et al.The Journal of Allergy and Clinical Immunology|September 15, 2005
Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levelsKoichi Hashimoto, Joan E Durbin, Weisong Zhou, et al.Pageof 53